<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">KJHEP</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-222X</issn>
      <issn pub-type="epub">2093-8047</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20924216</article-id>
      <article-id pub-id-type="pmc">3304593</article-id>
      <article-id pub-id-type="doi">10.3350/kjhep.2010.16.3.321</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of concomitant Gilbert's syndrome and hereditary spherocytosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Hee Jung</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moon</surname>
            <given-names>Hee Seok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Eaum Seok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Seok Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>Jae Kyu</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Byung Seok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>Hyun Yong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Heon Young</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eu</surname>
            <given-names>Young Jae</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Biology, School of Bioscience and Biotechnology, Chungnam National University, Daejeon, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Heon Young Lee. Department of Internal Medicine, Chungnam National University School of Medicine, 33 Munwha-ro, Jung-gu, Daejeon 301-721, Korea. Tel. +82-42-280-7163, Fax. +82-42-254-4553, <email>leehy@cnuh.co.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <volume>16</volume>
      <issue>3</issue>
      <fpage>321</fpage>
      <lpage>324</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>11</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>1</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>2</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2010 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We describe moderate hyperbilirubinemia in a 28-year-old man who suffered from gallstones and splenomegaly, with combined disorders of hereditary spherocytosis (HS) and Gilbert's syndrome (GS). Since it is difficult to diagnose HS in the absence of signs of anemia, we evaluated both the genetic mutation in the <italic>UGT1A1</italic> gene and abnormalities in the erythrocyte membrane protein; the former was heterozygous for a <italic>UGT1A1</italic> allele with three mutations and the latter was partially deficient in ankyrin expression. This is the first report of the concomitance of HS and GS with three heterozygous mutations [T-3279G, A (TA)7TAA, and G211A] in the <italic>UGT1A1</italic> gene.</p>
      </abstract>
      <kwd-group>
        <kwd>Hereditary spherocytosis</kwd>
        <kwd>Gilbert's syndrome</kwd>
        <kwd>
          <italic>UGT1A1</italic>
        </kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Gilbert's syndrome (GS) is characterized by unconjugated hyperbilirubinemia that occurs in the absence of bilirubinuria, overt hemolysis, or liver disease.<xref ref-type="bibr" rid="B1">1</xref> Decreased conjugation of bilirubin, due to diminished activity of the conjugation enzyme uridine diphosphate-glucuronosyltranferase (<italic>UGT1A1</italic>) is associated with an increased production of monoconjugated bilirubin.<xref ref-type="bibr" rid="B2">2</xref> Hereditary spherocytosis (HS) is a common inherited hemolytic anemia; it is heterogeneous in its clinical presentation, inheritance, molecular basis, and biochemical phenotype.<xref ref-type="bibr" rid="B3">3</xref> The characteristic features of HS include mild anemia, jaundice, and splenomegaly. The clinical severity varies, ranges from asymptomatic to severe life-threatening hemolytic anemia.<xref ref-type="bibr" rid="B3">3</xref> GS concomitant with HS is associated with higher bilirubin levels and a 5-fold increase in the tendency to develop cholelithiasis.<xref ref-type="bibr" rid="B2">2</xref> We describe moderate hyperbilirubinemia and gallstones in a male patient, who was given diagnosis of GS. Further evaluation of inappropriate hyperbilirubinemia led to detect a combination of HS with partial deficiency in ankyrin expression, and GS with heterozygous for a <italic>UGT1A1</italic> allele with 3 mutations (T-3279G (<italic>UGT1A1 60</italic>), A (TA)<sub>7</sub>TAA (<italic>UGT1A1 28</italic>), and G211A (<italic>UGT1A1 6</italic>)). These combined disorders are the first report in a Korean. We also present the various strategies for making these diagnoses and review the literature on these concomitant disorders.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 28-year-old man presented with watery diarrhea, abdominal discomfort, and fever. He had consumed a large amount of smoked, raw salmon the other day. He had been diagnosed with GS at the age of 12 years due to a history of intermittent unconjugated hyperbilirubinemia with normal liver function and underwent laparoscopic cholecystectomy for gallstones 1 year ago. The patient denied any family history. His height and weight were 179 cm and 69 kg, respectively. His body temperature was 37.6&#x2103;. Clinical examination revealed icteric sclera, mild tenderness over the whole abdomen, and hyperactive bowel sound. Laboratory tests revealed the following findings; white blood cell count, 13,700/uL; hemoglobin, 11.0 g/dL; mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC), 98 fL and 38 g/dL, respectively; aspartate aminotransferase, 21 IU/L; alanine aminotransferase, 20 IU/L; total bilirubin, 6.1 mg/dL; direct bilirubin, 0.8 mg/dL; gamma glutamyl transpeptidase, 11 IU/L; alkaline phosphatase, 54 IU/L. Abdominal computed tomography (CT) scan showed moderate splenomegaly and evidence of the previous cholecystectomy.</p>
      <p>We analyzed the laboratory and the radiologic findings. The highest total bilirubin level recorded was 10.3 mg/dL (9.6 mg/dL, unconjugated). There were two conflicting findings for GS diagnosis: moderate splenomegaly and high values of unconjugated hyperbilirubinemia. Moreover, he had previously undergone surgery for gallstones. Therefore, we conducted further examinations to identify additional causes or other disorders. Extensive laboratory tests revealed the followings; corrective reticulocyte count, 6.3%; lactate dehydrogenase, 529 IU/; and haptoblobin, 2 mg/dL. The findings of Coombs' direct and indirect tests were normal. We detected many small, dense spherocytes in peripheral blood smear. The osmotic fragility was increased (begin: 0.52%, end: 0.44% of NaCl). We suspected GS coexisting with underlying chronic hemolysis. We could not recognize his hemolytic state because the lowest hemoglobin level recorded in the past laboratory findings was 13.3 mg/dL. At that time of cholecystectomy, the gallstones observed, i.e., a black pigment stone and a cholesterol stone, had a size of 7 and 6 mm, respectively. To clarify the diagnosis of GS and HS, we performed DNA sequencing of the <italic>UGT1A1</italic> gene and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the red cell membrane proteins. Amplification of exons, the promoter region and enhancer regions (the phenobarbital responsive enhancer module, PBREM) of the <italic>UGT1A1</italic> was performed by the polymerase chain reaction of genomic DNA.<xref ref-type="bibr" rid="B4">4</xref> Amplified DNA fragments were sequenced directly.<xref ref-type="bibr" rid="B4">4</xref> We investigated red cell membrane protein defects of the patient using SDS-PAGE.<xref ref-type="bibr" rid="B5">5</xref> We found that the patient was heterozygous for a <italic>UGT1A1</italic> allele with three mutations (T-3279G (<italic>UGT1A1 60</italic>), A (TA)<sub>7</sub>TAA (<italic>UGT1A1 28</italic>), and G211A (<italic>UGT1A1 6</italic>)) (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The 3-dimensional structure of the <italic>UGT1A1</italic> protein was predicted by using the SWISS-MODEL (<xref ref-type="fig" rid="F2">Fig. 2</xref>). By using the Fairbanks system, we detected the decreased expression of ankyrin on SDS-PAGE (<xref ref-type="fig" rid="F3">Fig. 3</xref>). The patient was considered for splenectomy because of the likelihood of cholelithiasis despite the mild form of HS.</p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>The <italic>UGT1</italic> gene is located on chromosome 2q37. It encodes 9 functional proteins (<italic>UGT1A1</italic>, <italic>UGT1A3-10</italic>). The <italic>UGT1A</italic> locus includes 'first' exons and their associated promoters, which are spliced separately to four common exons (exons 2-5).<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref> Of the various UGTs characterized to date, particular attention has been paid to <italic>UGT1A1</italic>. Notably, this enzyme is solely responsible for bilirubin glucuronidation. Numerous mutations of <italic>UGT1A1</italic> that influence bilirubin glucuronidation have been identified. Many of these have been linked to syndromes, particularly GS and the Crigler-Najjar syndromes type I and II.<xref ref-type="bibr" rid="B6">6</xref> The incidence of GS is approximately 3~10% in the West and 3% in the East.<xref ref-type="bibr" rid="B8">8</xref> GS arises usually due to polymorphism in a TA-repeat element, A (TA)<sub>5-8</sub>TAA, of the <italic>UGT1A1</italic> promoter. Maruo et al.<xref ref-type="bibr" rid="B9">9</xref> reported linkage of GS to A (TA)<sub>7</sub>TAA (<italic>UGT1A1 28</italic>) and T-3279G (<italic>UGT1A1 60</italic>). An <italic>in vitro</italic> expression study has revealed that the A (TA)<sub>7</sub>TAA transcription activity is one-third of the normal value, and that T-3279G reduces the transcriptional activity to 60% of the normal value.<xref ref-type="bibr" rid="B9">9</xref> In addition, mutations in the coding region that result in reduced bilirubin-glucuronidation activity are also known to be associated with GS in an Asian population. The most prevalent mutation (13~23%) is G211A (<italic>UGT1A1 6</italic>), which results in the substitution of glycine for arginine at position 71 (G71R) of the <italic>UGT1A1</italic> protein.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B10">10</xref> An <italic>in vitro</italic> activity study showed that the G71R mutation reduced the total bilirubin glucuronidation activity by 50% as compared to its normal value.<xref ref-type="bibr" rid="B6">6</xref></p>
      <p>HS is a common inherited disorder that is characterized by anemia, jaundice, and splenomegaly. Although the clinical symptoms are variable, most patients presented with well-compensated hemolytic anemia. The primary lesion in HS is the loss of membrane surface area, leading to reduced deformability due to defects in the membrane proteins ankyrin, band 3, &#x3B1; spectrin, &#x3B2; spectrin, or protein 4.2.<xref ref-type="bibr" rid="B11">11</xref> Spherocytic red cells, precociously trapped in the spleen, are phagocytosed by splenic macrophages which results in chronic hemolysis.<xref ref-type="bibr" rid="B12">12</xref> Common complications are cholelithiasis, hemolytic episodes, and aplastic crisis. Removal of the spleen results in an increased red cell life span, decreased transfusion requirement, and a decreased incidence of gallstones. Splenectomy is thus the treatment of choice for moderate-to-severe forms of the disease.<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref></p>
      <p>In our case, HS concealed by GS was revealed because the patient suffered from food poisoning. Further evaluation showed that the patient was heterozygous for triple different mutations in the <italic>UGT1A1</italic> gene. In addition, the expression of the ankyrin protein was decreased in his erythrocyte membrane proteins. The unusually high levels of bilirubin observed in our case as compared to that reported for GS suggested the coexistence of an other disorder. However, the presence of two simultaneous causes of unconjugated hyperbilirubinemia may hamper the diagnosis. Sharma et al.<xref ref-type="bibr" rid="B13">13</xref> reported a similar case of HS combined with GS.</p>
      <p>GS is an heritable risk factor for gallstone formation resulting from impaired hepatic bilirubin clearance.<xref ref-type="bibr" rid="B14">14</xref> Moreover, GS concomitant with HS has been associated with higher levels of bilirubin and a 5-fold increase in the tendency to develop cholelithiasis.<xref ref-type="bibr" rid="B2">2</xref> Bile salts, calcium, or other biliary components could initiate the formation of pigment and cholesterol gallstones.<xref ref-type="bibr" rid="B2">2</xref> Our case suffered from cholecystitis with a black pigment stone and a cholesterol stone and had cholecystectomy, however, the potential risk of cholelithiasis remained because of the chronic hemolysis. Therefore, we made a plan of splenectomy. However, it must be emphasized that splenectomy involves a surgical risk as well as the risk postsplenectomy sepsis and atherosclerotic events.<xref ref-type="bibr" rid="B10">10</xref> It is not certain what extent the unconjugated hyperbilirubin level accounts for HS.</p>
      <p>Two linked polymorphic mutations (A (TA)<sub>7</sub>TAA and T-3279G)<xref ref-type="bibr" rid="B9">9</xref> and (A (TA)<xref ref-type="bibr" rid="B7">7</xref>TAA and G211A)<xref ref-type="bibr" rid="B10">10</xref> of <italic>UGT1A1</italic> were previously reported as the cause of GS. We performed amplification by polymerase chain reaction of genomic DNA and sequencing directly of promoter region, enhancer region exons of <italic>UGT1A1</italic>. To our knowledge, this is the first report of the concomitance of HS and 3 polymorphic, heterozygous mutations in the <italic>UGT1A1</italic> gene. Thus our patient had three linked heterozygous polymorphism, A (TA)<sub>7</sub>TAA a TA insertion mutation in TATA box of the promoter region, T-3279G, located in the phenobarbital responsive enhancer module (PBREM), and G71R in exon 1. We present the 3-dimensional structure of the <italic>UGT1A1</italic> protein that was predicted by using the SWISS-MODEL according to Li and Wu.<xref ref-type="bibr" rid="B15">15</xref> It shows the substitution of glycine for arginine at position 71 (G71R) of the <italic>UGT1A1</italic> protein.</p>
      <p>We used SDS-PAGE for the analysis of erythrocyte membrane protein abnormalities. In addition, we also detected the partial deficiency of ankyrin. Lee et al.<xref ref-type="bibr" rid="B3">3</xref> reported that ankyrin deficiency was the most common erythrocyte membrane protein defect in Korean HS patients.</p>
      <p>We report an interesting case of HS with partial deficiency of ankyrin expression and GS with mutations in promoter, enhancer, and one exon of the <italic>UGT1A1</italic> gene. Further evaluation is needed to determine the prognosis, and the therapeutic and genetic implications.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>GS</term>
          <def>
            <p>Gilbert's syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>UGT1A1</italic>
          </term>
          <def>
            <p>uridine diphosphate-glucuronosyltranferase</p>
          </def>
        </def-item>
        <def-item>
          <term>HS</term>
          <def>
            <p>hereditary spherocytosis</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sampietro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>lolascon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Molecular pathology of Crigler-Najjar type I and II Gilbert's syndromes</article-title>
          <source>Haematologica</source>
          <year>1999</year>
          <volume>84</volume>
          <fpage>150</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">10091414</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>del Giudice</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Perrotta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nobilli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Specchia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>d'Urzo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>lolascon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis</article-title>
          <source>Blood</source>
          <year>1999</year>
          <volume>94</volume>
          <fpage>2259</fpage>
          <lpage>2262</lpage>
          <pub-id pub-id-type="pmid">10498597</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Ra</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis</article-title>
          <source>J Korean Med Sci</source>
          <year>2000</year>
          <volume>15</volume>
          <fpage>284</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="pmid">10895969</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>The relationship between Gly71Arg and TATA box polymorphism of <italic>UGT1A1</italic> gene and prolonged hyperbilirubinemia of breast milk feeding infant in Korean</article-title>
          <source>Korean J Pediatr</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>150</fpage>
          <lpage>155</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ra</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Hur</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SDS-PAGE analysis of red cell membrane proteins in hereditary hemolytic anemia</article-title>
          <source>Korean J Hematol</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>559</fpage>
          <lpage>567</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Udomuksorn</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Elliot</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Machenzie</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Yoovathaworn</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miners</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates</article-title>
          <source>Pharmacogenet Genomics</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>1017</fpage>
          <lpage>1029</lpage>
          <pub-id pub-id-type="pmid">18004206</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sugimoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Iwasa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaito</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Linkage disequilibrium of <italic>UGT1A1</italic> 6 and <italic>UGT1A1</italic> 28 in relation to <italic>UGT1A6</italic> and <italic>UGT1A7</italic> polymorphisms</article-title>
          <source>Oncol Rep</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>801</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="pmid">16969497</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Yeon</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Byun</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A study of polymorphism in UDP-glucuronosyltransferase 1 (<italic>UGT-1A1</italic>) promoter gene in Korean patients with Gilbert's syndrome</article-title>
          <source>Korean J Hepatol</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>132</fpage>
          <lpage>138</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maruo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>D'Addario</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Two linked polymorphic mutations (A (TA)7TAA and T-3279G) of <italic>UGT1A1</italic> as the principal cause of Gilbert syndrome</article-title>
          <source>Hum Genet</source>
          <year>2004</year>
          <volume>115</volume>
          <fpage>525</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">15378351</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maruo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kurosawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsuchioka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe hyperbilirubinemia in a 10-year-old girl with a combined disorder of hereditary spherocytosis and Gilbert syndrome</article-title>
          <source>Pediatr Int</source>
          <year>2007</year>
          <volume>49</volume>
          <fpage>540</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">17587286</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perrotta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Mohandas</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spherocytosis</article-title>
          <source>Lancet</source>
          <year>2008</year>
          <volume>372</volume>
          <fpage>1411</fpage>
          <lpage>1426</lpage>
          <pub-id pub-id-type="pmid">18940465</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bader-Meunier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gauthier</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Archambaud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cynober</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mielot</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dommergues</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>399</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">11154215</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vukelja</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kadakia</surname>
            </name>
          </person-group>
          <article-title>Gilbert's syndrome co-existing with and masking hereditary spherocytosis</article-title>
          <source>Ann Hematol</source>
          <year>1997</year>
          <volume>74</volume>
          <fpage>287</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">9236515</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben Harosh-Katz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Patlas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hadas-Halpern</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Zimran</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elstein</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Inceased prevalence of cholelithiasis in Gaucher disease: association with splenectomy but not with Gilbert syndrome</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>586</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">15232362</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes</article-title>
          <source>BMC Evol Biol</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>69</fpage>
          <pub-id pub-id-type="pmid">17475008</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p><italic>UGT1A1</italic> nucleotide sequences amplified from the genomic DNA of the patient. (A) Nucleotide sequences of the mutated section of the phenobarbital-responsive enhancer module of <italic>UGT1A1</italic>. Arrows show the mutation points. Nucleotide T was replaced by G at position 3279 (i.e., T-3279G). The point mutation was heterozygous for T-3279G. (B) Nucleotide sequences of the TATA box in the <italic>UGT1A</italic> promoter. The mutation was heterozygous for seven repeats of TA in the TATA box [A(TA)7TAA]. (C) Nucleotide sequence of the mutated section of exon 1 of <italic>UGT1A1</italic>. There was a transition mutation at nucleotide 211 in exon 1 of <italic>UGT1A1</italic>. The substitution of adenine for guanine changed the codon from GGA to AGA, causing R to replace G at position 71 (i.e., G71R). The mutation was heterozygous for G71R.</p>
      </caption>
      <graphic xlink:href="kjhep-16-321-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Ribbon diagram of the predicted three-dimensional structure of <italic>UGT1A1</italic>. The figure was produced by homology-based modeling using the SWISS-MODEL and PyMOL molecular graphic systems. The short arrow (purple ribbons) indicates &#x3B1;-helices, and the long arrow indicates the &#x3B2;-sheet. The dotted arrow shows the substitution of arginine (R) for glycine (G) in codon 71 in the &#x3B1;-helix structure of the mutated <italic>UGT1A1</italic>, which does not cause a significant change in the tertiary structure of <italic>UGT1A1</italic>.</p>
      </caption>
      <graphic xlink:href="kjhep-16-321-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>SDS-PAGE gel stained with Coomassie brilliant blue and containing nine bands, with partial deficiency of ankyrin expression being evident from the Fairbanks system (arrow).</p>
        <p>C, normal control; P, patient.</p>
      </caption>
      <graphic xlink:href="kjhep-16-321-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
